Medication counts fell during follow-up, but the study lacked an untreated comparison.
The observational clinic cohort included 535 patients starting medicinal cannabis. Benzodiazepine, antidepressant and NSAID medication counts decreased over a year, while prescribed opioid counts did not show the same change. Adverse events were collected during routine visits, and most recorded events were classified as nonserious.
Continuous enrollment left fewer observations at later time points. Regression to the mean, concurrent care, selection and secular changes could explain part of the pattern. Medication counts do not establish equivalent doses, actual ingestion or a safe benzodiazepine discontinuation process. Industry affiliations were disclosed.
For an individual timeline, obtain the original drug doses, taper documentation, cannabis composition and symptom course. This cohort provides a signal for further study, not proof that cannabis replaced a benzodiazepine safely or caused its reduction.
Source: Publication PMC9663249. The case-review applications above are interpretive analysis.
Related reading: A Hip-Fracture Surgery Cohort Could Not Estimate Risk Among People Without Fractures.